Covered recipient · General Payments record
SARAH B WITTMAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$1,461.26
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $850.67 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $375.12 | 13 |
| Novo Nordisk AS | $217.83 | 14 |
| Amgen Inc. | $132.81 | 2 |
| GlaxoSmithKline, LLC. | $103.40 | 1 |
| Organon LLC | $21.51 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.25 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280713 | CMS |
| ABBVIE INC. | $13.80 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280715 | CMS |
| ABBVIE INC. | $8.87 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280717 | CMS |
| ABBVIE INC. | $6.17 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280719 | CMS |
| ABBVIE INC. | $9.88 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280721 | CMS |
| ABBVIE INC. | $11.26 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280723 | CMS |
| ABBVIE INC. | $24.74 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280725 | CMS |
| ABBVIE INC. | $14.88 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280727 | CMS |
| ABBVIE INC. | $101.33 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280729 | CMS |
| ABBVIE INC. | $26.00 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280731 | CMS |
| ABBVIE INC. | $14.83 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280733 | CMS |
| ABBVIE INC. | $11.45 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280735 | CMS |
| ABBVIE INC. | $124.66 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280737 | CMS |
| Amgen Inc. | $116.25 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115440341 | CMS |
| Amgen Inc. | $16.56 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115440337 | CMS |
| GlaxoSmithKline, LLC. | $103.40 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116690305 | CMS |
| Novo Nordisk Inc | $7.34 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096713541 | CMS |
| Novo Nordisk Inc | $5.80 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096930402 | CMS |
| Novo Nordisk Inc | $7.31 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096819963 | CMS |
| Novo Nordisk Inc | $4.52 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097182820 | CMS |
| Novo Nordisk Inc | $7.50 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097755385 | CMS |
| Novo Nordisk Inc | $115.06 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097775038 | CMS |
| Novo Nordisk Inc | $7.18 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096676587 | CMS |
| Novo Nordisk Inc | $13.65 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097144828 | CMS |
| Novo Nordisk Inc | $9.89 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097551579 | CMS |
| Novo Nordisk Inc | $6.92 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097478059 | CMS |
| Novo Nordisk Inc | $13.15 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097336777 | CMS |
| Novo Nordisk Inc | $8.22 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097220705 | CMS |
| Novo Nordisk Inc | $5.31 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097697047 | CMS |
| Novo Nordisk Inc | $5.98 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096597868 | CMS |
| Organon Llc | $4.51 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136289534 | CMS |
| Organon Llc | $17.00 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136289538 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.